Page last updated: 2024-08-18

pyrroles and gastrins

pyrroles has been researched along with gastrins in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19901 (7.69)18.7374
1990's0 (0.00)18.2507
2000's1 (7.69)29.6817
2010's7 (53.85)24.3611
2020's4 (30.77)2.80

Authors

AuthorsStudies
Ballinger, WF; Wise, L1
Fujita, Y; Inaba, F; Ito, K; Kinoshita, K; Morikawa-Inomata, Y; Shibakawa, N; Tabata, K; Tomizawa, A1
Chao, RC; Hara, K; Hashigaki, S; Igarashi, H; Imamura, M; Ito, T; Kimura, N; Kondo, S; Mizuno, N; Morizane, C; Murakami, M; Nishida, T; Ohki, E; Okusaka, T; Sawaki, A; Yamao, K1
Ashida, K; Chiba, T; Hiramatsu, N; Iwakiri, K; Kudou, K; Nishimura, A; Sakurai, Y; Umegaki, E1
Furuta, T; Hamaya, Y; Iwaizumi, M; Kagami, T; Miyajima, H; Osawa, S; Sugimoto, K; Suzuki, T; Uotani, T; Yamade, M1
Fukumoto, K; Higashino, K; Higuchi, K; Kojima, K; Kojima, Y; Sakaguchi, M; Sakamoto, H; Sanomura, M; Takata, K; Takeuchi, T; Tominaga, K1
Hanada, Y; Hoshikawa, Y; Hoshino, S; Iwakiri, K; Kaise, M; Kawami, N; Koizumi, E; Takenouchi, N; Umezawa, M1
Hoshikawa, Y; Hoshino, S; Iwakiri, K; Kaise, M; Kawami, N; Tanabe, T; Umezawa, M1
Goto, O; Hanada, Y; Hoshikawa, Y; Hoshino, S; Iwakiri, K; Kaise, M; Kawami, N; Takenouchi, N; Tanabe, T1
Furuta, T; Hamaya, Y; Higuchi, T; Iwaizumi, M; Kagami, T; Miyajima, H; Osawa, S; Sugimoto, K; Suzuki, T; Tani, S; Uotani, T; Yamade, M1
Higuchi, K; Hirata, Y; Kakimoto, K; Kinoshita, N; Kojima, Y; Koshiba, R; Miyazaki, T; Nakamura, S; Ota, K; Takeuchi, T; Tanaka, Y; Tawa, H; Tsujimoto, H; Ueda, Y1
Mazepa, ASW; Myers-Nodes, J1
Furuta, T; Hamaya, Y; Higuchi, T; Iwaizumi, M; Kagami, T; Osawa, S; Sugimoto, K; Takahashi, S; Tamura, S; Tani, S; Uotani, T; Yamade, M1

Trials

7 trial(s) available for pyrroles and gastrins

ArticleYear
Phase II study of sunitinib in Japanese patients with unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumor.
    Investigational new drugs, 2013, Volume: 31, Issue:5

    Topics: Adult; Aged; Angiogenesis Inhibitors; Asian People; Biomarkers, Tumor; Chromogranin A; Female; Gastrins; Humans; Indoles; Male; Middle Aged; Neoplasm Metastasis; Neuroendocrine Tumors; Pancreatic Neoplasms; Pyrroles; Sunitinib; Treatment Outcome

2013
Randomised clinical trial: a dose-ranging study of vonoprazan, a novel potassium-competitive acid blocker, vs. lansoprazole for the treatment of erosive oesophagitis.
    Alimentary pharmacology & therapeutics, 2015, Volume: 42, Issue:6

    Topics: Adult; Aged; Dose-Response Relationship, Drug; Double-Blind Method; Esophagitis; Female; Gastrins; Humans; Lansoprazole; Los Angeles; Male; Middle Aged; Proton Pump Inhibitors; Pyrroles; Sulfonamides

2015
Comparison of effect of an increased dosage of vonoprazan versus vonoprazan plus lafutidine on gastric acid inhibition and serum gastrin.
    European journal of clinical pharmacology, 2018, Volume: 74, Issue:1

    Topics: Acetamides; Adolescent; Adult; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Gastric Acid; Gastric Acidity Determination; Gastrins; Gastroesophageal Reflux; Healthy Volunteers; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Male; Piperidines; Proton Pump Inhibitors; Pyridines; Pyrroles; Sulfonamides; Young Adult

2018
Efficacy of On-Demand Therapy Using 20-mg Vonoprazan for Mild Reflux Esophagitis.
    Digestion, 2018, Volume: 97, Issue:4

    Topics: Aged; Esophagitis, Peptic; Fasting; Female; Gastrins; Humans; Japan; Maintenance Chemotherapy; Male; Middle Aged; Patient Satisfaction; Practice Guidelines as Topic; Prospective Studies; Proton Pump Inhibitors; Pyrroles; Recurrence; Severity of Illness Index; Sulfonamides; Treatment Outcome

2018
Effects of pirenzepine on vonoprazan-induced gastric acid inhibition and hypergastrinemia.
    European journal of clinical pharmacology, 2021, Volume: 77, Issue:7

    Topics: Cross-Over Studies; Female; Gastric Acid; Gastrins; Humans; Male; Pirenzepine; Proton Pump Inhibitors; Pyrroles; Sulfonamides; Young Adult

2021
Effect of a proton-pump inhibitor on intestinal microbiota in patients taking low-dose aspirin.
    European journal of clinical pharmacology, 2021, Volume: 77, Issue:11

    Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studies; Comorbidity; Dose-Response Relationship, Drug; Esomeprazole; Female; Gastrins; Gastrointestinal Hemorrhage; Gastrointestinal Microbiome; Hematocrit; Hemoglobins; Humans; Intestinal Mucosa; Lactobacillales; Male; Middle Aged; Polymorphism, Restriction Fragment Length; Prospective Studies; Proton Pump Inhibitors; Pyrroles; Sulfonamides

2021
Influence of daily versus alternate-day dosing of vonoprazan on intragastric pH, serum gastrin, and the antiplatelet function of clopidogrel : Influence of alternate-day dosing of vonoprazan.
    European journal of clinical pharmacology, 2022, Volume: 78, Issue:6

    Topics: Clopidogrel; Cross-Over Studies; Gastrins; Humans; Hydrogen-Ion Concentration; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Pyrroles; Sulfonamides

2022

Other Studies

6 other study(ies) available for pyrroles and gastrins

ArticleYear
Human gastric mucus: quantitative and qualitative studies.
    Surgical forum, 1969, Volume: 20

    Topics: Carbohydrates; Female; Gastric Mucosa; Gastrins; Glycosaminoglycans; Humans; Intubation, Gastrointestinal; Male; Mucus; Peptic Ulcer; Proteins; Pyrroles; Secretory Rate; Stress, Psychological

1969
The effect of subchronic administration of 7-(4-fluorobenzyloxy)-2,3-dimethyl-1-{[(1S,2S)-2-methylcyclopropyl]methyl}-1H-pyrrolo[2,3-d]pyridazine (CS-526), a novel acid pump antagonist, on gastric acid secretion and gastrin levels in rats.
    The Journal of pharmacology and experimental therapeutics, 2008, Volume: 326, Issue:1

    Topics: Animals; Circadian Rhythm; Dose-Response Relationship, Drug; Drug Administration Schedule; Gastric Acid; Gastrins; Male; Proton Pump Inhibitors; Proton Pumps; Pyridazines; Pyrroles; Rats; Rats, Sprague-Dawley

2008
Does the Novel Potassium-Competitive Acid Blocker Vonoprazan Cause More Hypergastrinemia than Conventional Proton Pump Inhibitors? A Multicenter Prospective Cross-Sectional Study.
    Digestion, 2018, Volume: 97, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Cross-Sectional Studies; Esophagitis, Peptic; Female; Gastrins; Gastritis, Atrophic; Humans; Long-Term Care; Male; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Pyrroles; Sulfonamides; Treatment Outcome; Young Adult

2018
Efficacy of on-demand therapy using 20-mg vonoprazan for non-erosive reflux disease.
    Esophagus : official journal of the Japan Esophageal Society, 2019, Volume: 16, Issue:2

    Topics: Aged; Drug Administration Schedule; Female; Gastrins; Gastroesophageal Reflux; Humans; Male; Middle Aged; Patient Satisfaction; Prospective Studies; Proton Pump Inhibitors; Pyrroles; Sulfonamides; Treatment Outcome

2019
Efficacy of long-term maintenance therapy with 10-mg vonoprazan for proton pump inhibitor-resistant reflux esophagitis.
    Esophagus : official journal of the Japan Esophageal Society, 2019, Volume: 16, Issue:4

    Topics: Aged; Drug Resistance; Endoscopy, Gastrointestinal; Esophagitis, Peptic; Female; Gastric Mucosa; Gastrins; Humans; Maintenance Chemotherapy; Male; Middle Aged; Proton Pump Inhibitors; Pyrroles; Recurrence; Sulfonamides; Symptom Assessment; Time Factors

2019
Combined surgical and medical management of a cat with gastrinoma.
    The Journal of small animal practice, 2022, Volume: 63, Issue:8

    Topics: Animals; Cat Diseases; Cats; Duodenal Neoplasms; Female; Gastrinoma; Gastrins; Omeprazole; Pancreatic Neoplasms; Pyrroles

2022